Position in PFE
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$314,195
-$30,795 QoQ
Shares Held
13,048
+6.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#2,096
of 2,821 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Crewe Advisors LLC holds $5,785,083 across 15 Drug Manufacturers - General names. PFE ranks #7 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
10,490 | $1,347,965 | |
| 2 | LLY |
ELI LILLY & Co
|
962 | $1,153,851 | |
| 3 | JNJ |
Johnson & Johnson
|
3,263 | $828,704 | |
| 4 | ABBV |
AbbVie Inc.
|
2,981 | $750,138 | |
| 5 | AMGN |
Amgen Inc
|
1,376 | $498,277 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,950 | $458,079 | |
| 7 | PFE |
Pfizer Inc
This page
|
13,048 | $314,195 | |
| 8 | AZN |
Astrazeneca PLC
|
967 | $183,362 |
All Filings in PFE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $314,195 | 13,048 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $344,990 | 12,286 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $305,099 | 12,253 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $303,670 | 11,918 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $322,852 | 13,319 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $332,030 | 13,103 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $350,647 | 13,217 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $418,761 | 14,470 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $410,074 | 14,656 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $409,312 | 14,750 | Shares | Sole | 2024-05-14 | |
| 2023-06-30 | $484,359 | 13,205 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $586,581 | 14,377 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $724,943 | 14,148 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $678,936 | 15,515 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $773,080 | 14,745 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $657,064 | 12,692 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $531,686 | 9,004 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $363,606 | 8,454 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $333,212 | 8,509 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $380,704 | 10,508 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $380,983 | 10,350 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $288,241 | 7,854 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $203,721 | 6,230 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $203,346 | 6,230 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||